Left atrial appendage exclusion for stroke prevention in atrial fibrillation

Taral K. Patel, Clyde W. Yancy, Bradley P. Knight*

*Corresponding author for this work

Research output: Contribution to journalReview article

13 Scopus citations

Abstract

The public health burden of atrial fibrillation (AF) and associated thromboembolic stroke continues to grow at alarming rates. AF leads to a fivefold increase in the risk of stroke. Therefore, stroke prevention remains the most critical aspect of AF management. Current standard of care focuses on oral systemic anticoagulation, most commonly with warfarin and now with newer agents such as dabigatran, rivaroxaban, and apixaban. However, the challenges and limitations of oral anticoagulation have been well documented. Given the critical role of the left atrial appendage (LAA) in the genesis of AF-related thromboembolism, recent efforts have targeted removal or occlusion of the LAA as an alternative strategy for stroke prevention, particularly in patients deemed unsuitable for oral anticoagulation. This paper highlights recent advances in mechanical exclusion of the LAA. The problem of AF and stroke is briefly summarized, followed by an explanation for the rationale behind LAA exclusion for stroke prevention. After briefly reviewing the history of LAA exclusion, we highlight the most promising LAA exclusion devices currently available. Finally, we discuss future challenges and opportunities in this growing field.

Original languageEnglish (US)
Article number610827
JournalCardiology Research and Practice
Volume1
Issue number1
DOIs
StatePublished - Nov 19 2012

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Left atrial appendage exclusion for stroke prevention in atrial fibrillation'. Together they form a unique fingerprint.

  • Cite this